Oppenheimer raised the firm’s price target on Camtek (CAMT) to $195 from $180 and keeps an Outperform rating on the shares. The firm notes Camtek’s Q1 revenue was slightly ahead and the Q2 revenue target of $129M-$131M is up sequentially. Management also guided second half of 2026 revenue more than 25% higher vs. the first half, supported by record orders and over $260M expected 2026-2027 revenue from two HBM customers. Despite that, the stock was down 16% on elevated expectations.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on CAMT:
